Aclarion Announces Nociscan® Now Available at Goodman Campbell Brain & Spine at Ascension St. Vincent, First Site in Indiana to Offer the Technology

* Partnership brings Nociscan for chronic low back pain to one of the nation's leading neurosurgery and spine care networks * Goodman Campbell Brain & Spine is recognized nationally for its role in neurosurgery training and clinical research * Availability of Nociscan in Indiana reflects Company’s focus on expansion and adding to its growing base of provider sites across the country BROOMFIELD, Colo., Aug. 04, 2026 (GLOBE NEWSWIRE) -- Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a commercial-stage healthcare technology company leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to help physicians identify the location of chronic low back pain, today announced that its Nociscan platform is now available at Goodman Campbell Brain & Spine at Ascension St. Vincent, marking the first site in Indiana to offer the technology.

The addition of Goodman Campbell Brain & Spine extends Aclarion's provider network into a new state and aligns the Company with a center that is consistently ranked among the best in the nation. As a leader in neurosurgery training and clinical research, the physician specialists are recognized for their commitment to cutting-edge approaches and treatment, and data-driven outcome measures to improve the health of their patients.